806 related articles for article (PubMed ID: 15364002)
21. Characterization of kappa and delta opioid receptors in isolated organs by using type/subtype selective agonists and antagonists.
Makó E; Rónai AZ
Med Sci Monit; 2001; 7(3):350-6. PubMed ID: 11386008
[TBL] [Abstract][Full Text] [Related]
22. Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and the hamster vas deferens.
Sagan S; Corbett AD; Amiche M; Delfour A; Nicolas P; Kosterlitz HW
Br J Pharmacol; 1991 Oct; 104(2):428-32. PubMed ID: 1665735
[TBL] [Abstract][Full Text] [Related]
23. Two new opioid delta-receptor ligands: a highly selective agonist and a potent selective antagonist in in vitro isolated preparations.
Ueki M; Aoki K; Kajiwara M; Shinozaki K; Inoue H; Oka T
Jpn J Pharmacol; 1984 Dec; 36(4):485-9. PubMed ID: 6098760
[TBL] [Abstract][Full Text] [Related]
24. Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism.
Balboni G; Salvadori S; Guerrini R; Negri L; Giannini E; Bryant SD; Jinsmaa Y; Lazarus LH
J Med Chem; 2004 Jul; 47(16):4066-71. PubMed ID: 15267245
[TBL] [Abstract][Full Text] [Related]
25. Probes for narcotic receptor-mediated phenomena. 21. Novel derivatives of 3-(1,2,3,4,5,11-hexahydro-3-methyl-2,6-methano-6H-azocino[4,5-b]indol- 6-yl)-phenols with improved delta opioid receptor selectivity.
Bertha CM; Ellis M; Flippen-Anderson JL; Porreca F; Rothman RB; Davis P; Xu H; Becketts K; Rice KC
J Med Chem; 1996 May; 39(10):2081-6. PubMed ID: 8642567
[TBL] [Abstract][Full Text] [Related]
26. Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptor.
Corbett AD; Gillan MG; Kosterlitz HW; McKnight AT; Paterson SJ; Robson LE
Br J Pharmacol; 1984 Sep; 83(1):271-9. PubMed ID: 6091824
[TBL] [Abstract][Full Text] [Related]
27. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ
J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329
[TBL] [Abstract][Full Text] [Related]
28. Binding selectivity of short [D-Arg2,Leu5]enkephalin analogues to mu- and delta-subclasses of opiate receptors.
Rosenthal GF; Inkina NM; Abissova NA; Bobrova IV; Chipens GI
Biomed Sci; 1990 Apr; 1(4):414-6. PubMed ID: 1966782
[TBL] [Abstract][Full Text] [Related]
29. Cyclic enkephalin analogs containing various para-substituted phenylalanine derivatives in place of Tyr1 are potent opioid agonists.
Weltrowska G; Lemieux C; Chung NN; Schiller PW
J Pept Res; 2005 Jan; 65(1):36-41. PubMed ID: 15686532
[TBL] [Abstract][Full Text] [Related]
30. Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo.
Kramer TH; Shook JE; Kazmierski W; Ayres EA; Wire WS; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1989 May; 249(2):544-51. PubMed ID: 2566679
[TBL] [Abstract][Full Text] [Related]
31. Proglumide exhibits delta opioid agonist properties.
Rezvani A; Stokes KB; Rhoads DL; Way EL
Alcohol Drug Res; 1987; 7(3):135-46. PubMed ID: 3030338
[TBL] [Abstract][Full Text] [Related]
32. Delta and kappa opioid receptors in the rabbit ear artery.
Berzetei IP; Fong A; Duckles SP
NIDA Res Monogr; 1986; 75():105-8. PubMed ID: 2828953
[TBL] [Abstract][Full Text] [Related]
33. Site-directed alkylation of multiple opioid receptors. II. Pharmacological selectivity.
Goldstein A; James IF
Mol Pharmacol; 1984 May; 25(3):343-8. PubMed ID: 6328260
[TBL] [Abstract][Full Text] [Related]
34. 3-(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-alkyl-N-arylbenzamides: potent, non-peptidic agonists of both the micro and delta opioid receptors.
Bishop MJ; Garrido DM; Boswell GE; Collins MA; Harris PA; McNutt RW; O'Neill SJ; Wei K; Chang KJ
J Med Chem; 2003 Feb; 46(4):623-33. PubMed ID: 12570383
[TBL] [Abstract][Full Text] [Related]
35. Cyclic penicillamine containing enkephalin analogs display profound delta receptor selectivities.
Mosberg HI; Hurst R; Hruby VJ; Gee K; Akiyama K; Yamamura HI; Galligan JJ; Burks TF
Life Sci; 1983; 33 Suppl 1():447-50. PubMed ID: 6319901
[TBL] [Abstract][Full Text] [Related]
36. Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency.
Cox BM; Chavkin C
Mol Pharmacol; 1983 Jan; 23(1):36-43. PubMed ID: 6135144
[No Abstract] [Full Text] [Related]
37. Postnatal development of delta-opioid receptor subtypes in mice.
Negri L; Severini C; Lattanzi R; Potenza RL; Melchiorri P
Br J Pharmacol; 1997 Mar; 120(6):989-94. PubMed ID: 9134207
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of stable and potent delta/mu opioid peptides: analogues of H-Tyr-c[D-Cys-Gly-Phe-D-Cys]-OH by ring-closing metathesis.
Mollica A; Guardiani G; Davis P; Ma SW; Porreca F; Lai J; Mannina L; Sobolev AP; Hruby VJ
J Med Chem; 2007 Jun; 50(13):3138-42. PubMed ID: 17539621
[TBL] [Abstract][Full Text] [Related]
39. Dalargin and [Cys-(O2NH2)]2 analogues of enkephalins and their selectivity for mu opioid receptors.
Pencheva N; Ivancheva C; Dimitrov E; Bocheva A; Radomirov R
Gen Pharmacol; 1995 Jul; 26(4):799-808. PubMed ID: 7635255
[TBL] [Abstract][Full Text] [Related]
40. Cerebral delta opioid receptors mediate analgesia but not the intestinal motility effects of intracerebroventricularly administered opioids.
Galligan JJ; Mosberg HI; Hurst R; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1984 Jun; 229(3):641-8. PubMed ID: 6327967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
